Showing results (41-50 of 102) with videos related to

Sort By:
Pageof 11
The Journal of Pharmacy and Pharmacology|April 6, 2021
Eugenol modulates insulin sensitivity by upregulating insulin receptor substrate-2 in non-alcoholic fatty liver disease in ratsMariam H Fawzy, Noha M Saeed, Doaa A El-Sherbiny, et al.
Plos One|July 23, 2013
Multimechanistic antifibrotic effect of biochanin a in rats: implications of proinflammatory and profibrogenic mediatorsRanda M Breikaa, Mardi M Algandaby, Ebtehal El-Demerdash, et al.
Clinical and Experimental Pharmacology & Physiology|May 12, 2016
Deferoxamine alleviates liver fibrosis induced by CCl4 in ratsAya Mohammed, Ekram N Abd Al Haleem, Wesam M El-Bakly, et al.
Cancer Chemotherapy and Pharmacology|July 25, 2003
New aspects in probucol cardioprotection against doxorubicin-induced cardiotoxicityEbtehal El-Demerdash, Azza A Ali, Mohamed M Sayed-Ahmed, et al.
European Journal of Drug Metabolism and Pharmacokinetics|December 25, 2016
Antifibrotic Effects of Carvedilol and Impact of Liver Fibrosis on Carvedilol Pharmacokinetics in a Rat modelEbtehal El-Demerdash, Somaia A Abdel-Sattar, Wesam M El-Bakly, et al.
BMC Pharmacology & Toxicology|April 14, 2023
Effect of renin angiotensin blockers on angiotensin converting enzyme 2 level in cardiovascular patientsSarah Farid Fahmy, Marwa Omar El Derany, Hazem Khorshid, et al.
Environmental Toxicology and Pharmacology|July 26, 2011
Acrylonitrile-induced toxicity and oxidative stress in isolated rat colonocytesAhmed M Mohamadin, Ebtehal El-Demerdash, Hesham A El-Beshbishy, et al.
Drug Development Research|February 4, 2021
Naringin treatment improved main clozapine-induced adverse effects in rats; emphasis on weight gain, metabolic abnormalities, and agranulocytosisMina Y George, Esther T Menze, Ahmed Esmat, et al.
Diabetology & Metabolic Syndrome|July 2, 2010
Effect of taurine supplementation on hyperhomocysteinemia and markers of oxidative stress in high fructose diet induced insulin resistanceHala O El Mesallamy, Ebtehal El-Demerdash, Lamiaa N Hammad, et al.
Cancer Chemotherapy and Pharmacology|December 18, 2015
Selective A3 adenosine receptor agonist protects against doxorubicin-induced cardiotoxicityAya Galal, Wesam M El-Bakly, Ekram Nemr Abd Al Haleem, et al.
Pageof 11